RhumbLine Advisers’s CorMedix CRMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.14M | Buy |
92,905
+11,340
| +14% | +$140K | ﹤0.01% | 2178 |
|
|
2025
Q1 | $502K | Buy |
81,565
+5,818
| +8% | +$35.8K | ﹤0.01% | 2574 |
|
|
2024
Q4 | $614K | Buy |
75,747
+6,028
| +9% | +$48.8K | ﹤0.01% | 2534 |
|
|
2024
Q3 | $563K | Sell |
69,719
-4,520
| -6% | -$36.5K | ﹤0.01% | 2624 |
|
|
2024
Q2 | $321K | Buy |
74,239
+11,339
| +18% | +$49.1K | ﹤0.01% | 2956 |
|
|
2024
Q1 | $267K | Sell |
62,900
-5,982
| -9% | -$25.4K | ﹤0.01% | 3041 |
|
|
2023
Q4 | $259K | Buy |
68,882
+12,186
| +21% | +$45.8K | ﹤0.01% | 3048 |
|
|
2023
Q3 | $210K | Buy |
56,696
+7,141
| +14% | +$26.4K | ﹤0.01% | 3137 |
|
|
2023
Q2 | $196K | Buy |
+49,555
| New | +$196K | ﹤0.01% | 3248 |
|
|
2022
Q2 | – | Sell |
-42,331
| Closed | -$232K | – | 3123 |
|
|
2022
Q1 | $232K | Sell |
42,331
-1,018
| -2% | -$5.58K | ﹤0.01% | 2723 |
|
|
2021
Q4 | $197K | Sell |
43,349
-7
| -0% | -$32 | ﹤0.01% | 2838 |
|
|
2021
Q3 | $202K | Buy |
43,356
+317
| +0.7% | +$1.48K | ﹤0.01% | 2912 |
|
|
2021
Q2 | $295K | Buy |
43,039
+18,488
| +75% | +$127K | ﹤0.01% | 2791 |
|
|
2021
Q1 | $245K | Sell |
24,551
-1,870
| -7% | -$18.7K | ﹤0.01% | 2772 |
|
|
2020
Q4 | $196K | Buy |
26,421
+6,081
| +30% | +$45.1K | ﹤0.01% | 2844 |
|
|
2020
Q3 | $123K | Sell |
20,340
-4,115
| -17% | -$24.9K | ﹤0.01% | 2829 |
|
|
2020
Q2 | $154K | Buy |
24,455
+4,993
| +26% | +$31.4K | ﹤0.01% | 2855 |
|
|
2020
Q1 | $70K | Hold |
19,462
| – | – | ﹤0.01% | 2833 |
|
|
2019
Q4 | $142K | Buy |
19,462
+132
| +0.7% | +$963 | ﹤0.01% | 2828 |
|
|
2019
Q3 | $123K | Buy |
19,330
+730
| +4% | +$4.65K | ﹤0.01% | 2851 |
|
|
2019
Q2 | $167K | Buy |
+18,600
| New | +$167K | ﹤0.01% | 2834 |
|
|
2016
Q2 | – | Sell |
-6,987
| Closed | -$93K | – | 2990 |
|
|
2016
Q1 | $93K | Buy |
6,987
+1,010
| +17% | +$13.4K | ﹤0.01% | 2906 |
|
|
2015
Q4 | $61K | Buy |
5,977
+618
| +12% | +$6.31K | ﹤0.01% | 2991 |
|
|
2015
Q3 | $53K | Buy |
5,359
+225
| +4% | +$2.23K | ﹤0.01% | 2990 |
|
|
2015
Q2 | $100K | Buy |
+5,134
| New | +$100K | ﹤0.01% | 3005 |
|